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Summary 
Substantial numbers of both cr  and 3'//i T cells are present in human fetal liver, which suggests 
a role of the fetal liver in T  cell development. The diversity of fetal liver T  cell receptor (TCK) 
3' and ~ chain rearrangements  was examined among both CD4+CD8 -  and CD4-CDS-  3'/c5 
T  cell clones. In addition,  TCR 5 chain transcripts from three fetal livers were sequenced after 
polymerase chain reaction amplification of TCR $ chains with V~I or Va2 rearrangements.  Five 
of six fetal liver 3'//t T cell clones had a Va2-Da3-Ja3 gene rearrangement with limited junctional 
diversity;  three  of these  clones  had  an  unusual  CD4+CD8 -  phenotype.  V~2-D63-J63  gene 
rearrangements were also common among both in-frame and out-of-frame transcripts from three 
fetal livers, indicating that they are the result of an ordered rearrangement process. TCK 3' chain 
sequences  of the  fetal  liver  3'/~5 T  cell  clones  revealed  V~l-J,2.3,  V,2-J,1.2,  and  V,3-J,l.1 
rearrangements with minimal incorporation of template-independent N region nucleotides. TCR 
3' chain rearrangements  found in these fetal liver T  cell clones were different from those that 
have been observed among early thymic 3"/c5 T  cell populations,  while similar  TCK/i  chain 
rearrangements  are found among 3'/~5 T  cells from both sites. These data demonstrate that the 
fetal liver harbors 3'/~5 T cell populations distinct from those found in the fetal thymus, suggesting 
that the fetal liver is a site of 3'//t T cell development in humans. These unusual T cell populations 
may serve a specific  function in  the fetal immune  system. 
3"/c5 T  cells  are a distinct  subset of mature T  cells  defined 
by the expression of rearranged  TCR 3" and ~5 genes (1, 2). 
A number of studies performed in mice have demonstrated 
a developmental pattern of3'/5 TCK rearrangements as well 
as localization of 3'/~5 T  cells with defined TCR rearrange- 
ments to specific organs. For example, 3'//t T cells in mouse 
intestinal mucosa and mesenteric lymph nodes preferentially 
use V,7,  while 3'/~5 T  cells  in  skin use the Vv3 gene seg- 
ment (3, 4). Such epithelial 3'/c5 T cells are thought to have 
specific  functions  in  the immune  surveillance  of epithelial 
tissues, such as the lysis of infected or transformed cells (5). 
In humans,  the developmental pattern of 3'/~5 TCR rear- 
rangements is not as well understood as it is in mice. Neverthe- 
less, there is evidence that the occurrence of human 3"/c5 T 
cell populations  is also developmentally regulated.  In fetal 
thymus, the major population of TCK c5 chains is rearranged 
to the V~2 gene segment, while Val § T  cells represent the 
major population of3'/5 T cells in postnatal thymus and blood 
of newborns (6-9). However, 6 mo after birth V62 + 3'/r  T 
cells become the predominant 3,//t T cell population in blood 
while V~I §  T  cells  continue  to be the  major  3'/8  T  cell 
population  in  the thymus  (10,  11). 
Murine fetal liver is not only a site at which T cell precursors 
develop from immature cells but also an organ in which 3'/li 
T  cells can mature.  Nude mice were found to have substan- 
tial numbers of intestinal intraepithelial  3,/c5 T  cells despite 
the almost complete absence of ot/B T  cells.  Furthermore, 
intraepithelial 3'/~ T  cells could be reconstituted in lethally 
irradiated mice by injection of fetal liver precursors, even in 
thymectomized animals  (12).  Since at least a subset of 3'//i 
T  cells is thymus independent,  fetal  liver is a likely site of 
extrathymic 3'/~5 T  cell maturation. 
The presence of substantial numbers of3"/~ T cells in human 
fetal liver as well as the unusual CD4 + phenotype of a sub- 
population of fetal liver 3'//~ T  cells support the hypothesis 
that fetal liver is also a site of extrathymic 3'//t T cell matura- 
tion in humans.  Both ot//~  and 3'/c5 T  cells have been cul- 
tured from human fetal liver and represent '~63 and '~32% 
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and  CD8  molecules,  three  subsets  of  CD3 +  T  cells  in 
human fetal liver were identified. Approximately 20% of fetal 
liver 3'/8 T  ceils have a CD4+CD8 -  phenotype that is in- 
frequent among 3'/8 T  ceils in thymus or blood. In contrast 
to CD4-CD8-  and CD4-CD8 + 3'/8 T  cells,  CD4+CD8 - 
3'/8 T  cells from fetal liver were found to lack cytotoxic ac- 
tivity (13-15).  Together,  these data suggest  that  fetal liver 
y/8 T cells represent a distinct T cell population. In the present 
paper, TCR 3/and 8 chain rearrangements of CD4+CD8 - 
and CD4-CD8-  fetal liver "//8 T  cell clones were exam- 
ined. The data indicate that fetal liver 3'/8 T  cells represent 
T  cell populations  distinct  from thymic y/8 T  cells. 
Materials and Methods 
Cell Preparations.  Fetal liver samples FL 2/9, FL 2/27, FL 1/9, 
and FL 5/27 were obtained at the time of postmortem examina- 
tion from electively aborted fetuses after 20-22 wk of gestation 
(FL 2/9, 21 wk; FL 2/27, 20 wk; FL 1/9, 22 wk; FL 5/27,  20 
wk). The consent forms and collecting practices  were approved 
by the Committee for the Protection of Human Subjects from Re- 
search Risks (Boston, MA). FL 2/9 liver cell suspension  was pre- 
pared by gently teasing tissue, and cells were frozen down immedi- 
ately in 90% FCS,  10% DMSO at  -80~  FL 2/27 and FL 1/9 
single cell suspensions  were prepared in a similar fashion, stimu- 
lated with PHA for 14 d to enrich for T cells, and frozen in 90% 
FCS, 10% DMSO at  - 80~  PBL were isolated by Ficoll density 
gradient centrifugation from blood of a normal adult volunteer. 
FACS  ~ Analysis.  Antibodies used for immunofluorescence anal- 
ysis were: T3b (anti-CD3), OKT4 (anti-CD4), Leu2A (anti-CD8), 
WT31 (TCR ~/3 >> TCR y/~; Becton Dickinson & Co., Moun- 
tain View, CA), TCR-~$1 (anti-TCR ~$ chain;  16), c$TCS1 (anti- 
TCR Val-Jal;  17), BB3 (anti-TCR Va2; 18), and Ti~A (anti-TCR 
Vv9; 19). Cells were incubated with saturating amounts of pri- 
mary antibodies or isotype-matched control antibodies in PBS/5% 
normal human serum for 30 min at 4~  and washed in PBS, 1% 
BSA. Cells were then incubated with FITC-labeled goat anti-mouse 
antibody  (Cappel  Laboratories,  Malvern,  PA)  for 30  minutes, 
washed, and fixed in 1% formaldehyde, PBS. Fluorescence staining 
was examined using an Epics C  cell sorter (Coulter Electronics, 
Inc., Hialeah, FL). 
T Cell Cloning.  Fetal liver T cell clones L3, L6, L7, L25, and 
L38 were isolated  from FL 5/27 by direct single cell cloning on 
day 0, while fetal liver clones L2G9, L4B2, L7F11, L4G1, and L7F5 
were generated from FL 2/9 after enrichment of TCR ~§ T cells 
by magnetic bead separation.  For cloning, T cells were grown in 
RPMI, 10% human serum (Biocell), 10-20% conditioned media 
(delectinized supematant from PHA-stimulated  blood mononuclear 
cells) at one cell/well in U-bottomed microtiter plates using 2  x 
104 irradiated mononuclear cells and  104 irradiated JY cells  (an 
EBV-transformed B cell line) per well. After 2 wk, growth-positive 
wells were expanded with fresh feeder cells and IL-2. 
For bead selection,  fetal liver cells were incubated with TCK-6I 
mAb (1:500 dilution of ascites) in RPMI, 2% FCS for 30 min at 
4~  and washed in RPMI, 3% BSA. Antibody-coated cells were 
incubated with magnetic goat anti-mouse beads  (Dynal) for 15 
min at 37~  and TCK-~l-positive cells recovered by magnetic bead 
separation  and repeated washing of beads. Cells were cultured for 
1-3 wk and cloned as described above. 
RNA Preparation and cDNA Synthesis.  RNA was prepared from 
0.5-10  x  106 cells using the RNAzol B method (Cinna/Biotecx). 
Cells were washed twice with PBS and then homogenized in 1 
ml of KNAzol B. 100/zl of chloroform was added and the sample 
centrifuged at 4~  The upper, clear phase  was transferred to a 
clean tube arid RNA was precipitated by addition of an equal volume 
ofisopropanol. When small numbers of  cells were available  for RNA 
preparation,  10 #g of tRNA was added as a carrier in the isopropanol 
precipitation step. After a 15-min incubation on ice, samples were 
centrifuged at 4~  The RNA pellet was washed with 1 ml of 
cold 70% ethanol and air dried. RNA was resuspended  in 10 #1 
of autoclaved  H20 and stored at  -80~  cDNAs were synthe- 
sized from 1-2 #g of KNA using oligo(dT) as a primer and AMV- 
reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, 
MD) (20). cDNAs were diluted to 200 #1 with autoclaved  H20 
and stored at  -80~  5-10 #I of diluted cDNA was used for each 
PCR amplification. 
PCR Amplification and Southern Blot Analysis.  cDNAs from 
PBL,FL 2/9, FL 2/27, and FL 1/9 samples were amplified for 35 
cycles in 50-#1 reactions using AmpliTaq  polymerase as recom- 
mended by the manufacturer (Perkin Elmer Cetus, Norwalk, CT). 
PCR cycles were 94~  denaturation (1 min), 55~  annealing (2.0 
min), and 72~  extension (3.0 min). A different PCK program 
was used for amplification of the TCK ~ chain from fetal liver T cell 
clones L3, L25, L2G9 (30 cycles of 94~  denaturation [1.5 min], 
48~  annealing [1.5 min], and 72~  extension (1.5 min D. Primers 
used were specific for V+I to Va5 chains and used in combination 
with a Ca primer (0.5/~g of each primer per reaction). Sequences 
of oligonucleotides used for PCR or for Southern blot hybridization 
were: Val, 5' ggggtcgacaagttggtggtcatatta-3'; Va2, 5' ggggtcgac- 
cctcaggtgctccatgaa-3'; V63, 5' ggggtcgacactgtatattcaaatc-Y; Va4, 
5' ggggtcgaccagcaagttaagcaa-3';  VaS, 5' ggggtcgacatatgacaccag- 
tgatc-Y;  C~coRI, 5' ggggtagaattccttcacca-3';  Ca, 5' gcaaacagcatt- 
cgtagcccaagcactgtg 3'; Ca probe, 5' gtcatgaaaaatggaacaaatgtcgct- 
tgt-3'; J+l, 5' ccacagtcacacgggttcct  3'; Ja2, 5' ccacgatgagttgtgttccc 
3'; Ja3, 5' ccgaaaaacatctgtcgggt 3'; Vsl, 5' tacatccactggtacctacac- 
cagga 3'; V~2, 5' ggggtcgacctggtgaagtcatacagt 3'; V~3, 5' ggggaa- 
ttcacaaggtttgaaacagat g 3'; Vv4, 5' ggggaattccaaggctttagcagtaaaa 
3'; Cv-BamHI, 5' tcctgggatcccagaatcgtgttgct 3'; Cv-PstI,  5' tgt- 
ttgtgagctgcagcagtagtgta 3'. 
Val  to Va5 primers have a SalI restriction site for cloning of 
PCR products into M13 vectors, while one of the Ca primers has 
an EcoRI restriction site to facilitate cloning. For amplification  of 
TCR 3/chains, Vv primers were used in combination with either 
Cv primer (Cv-BamHI is located closer to the 5' end of Cs). To 
prevent contamination of samples, reagents used for cDNA syn- 
thesis and PCK amplification  were tested for possible contamina- 
tion. Negative controls (all primer combinations, no cDNA) were 
included in experiments in order to detect accidental contamination. 
PCK products were analyzed on 1% agarose gels stained with 
ethidium bromide. For Southern blot analysis, gels were denatured, 
neutralized, and PCR products transferred to nitrocellulose paper 
(Schleicher & Schuell, Inc., Keene, NH). Amplified DNA was hy- 
bridized to an internal Ca olignnucleotide probe endlabeled using 
3-[32p]ATP  and  T4  polynucleotide kinase  (Bethesda  Research 
Laboratories).  Hybridizations were performed for 18 h at 37~  in 
a buffer containing 6 x  SSC, 0.05 % pyrophosphate,  5 x  Denhardt's, 
0.5% SDS, 0.1 mg/ml of denatured salmon sperm DNA.  After 
hybridization at 37~  for 18 h, filters were washed at a final strin- 
gency of6x  SSC, 70~  (C+ probe) or 6x  SSC, 50~  (Ja probes) 
and processed  for autoradiography (20). 
DNA  Sequence Analysis.  V+-Ca PCK  products,  M13  mp19 
plasmid DNA, and pUC-18 DNA were digested with EcoKI and 
SalI  restriction  endonucleases  to  generate  compatible  ends  for 
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phosphatase (Bethesda  Research  Laboratories). Digested PCR prod- 
ucts were gel purified, ligated to plasmid DNA, and used to trans- 
form  JM101-competent cells. PCR products from fetal liver T cell 
clones were cloned into pUC-18 while TCR/~ chain amplification 
products from fetal liver were cloned into M13 rap19. DNA was 
sequenced by the dideoxy method (21) using the M13 universal 
primer and c~-3sS-ATP as radiolabeled nucleotide. For  sequence 
analysis  of  TCR 3' chains, PCR products were cloned into the pCRII 
vector (TA cloning system; Invitrogen, San Diego, CA) double- 
stranded plasmid DNA was sequenced  by the dideoxy method using 
C~-BamHI as a primer. 
Results 
Analysis of TCR 8 Chain Rearrangements in Human Fetal 
Liver.  The TCR/~ chain repertoire in human fetal liver was 
examined by PCR amplification of cDNAs synthesized from 
fetal liver IkNA (using primers specific for V01 to V05 gene 
segments in combination with a Ca primer). RNA was ex- 
tracted from one fetal liver tissue sample (FL 2/9) and from 
two samples (FL 2/27 and FL 1/9) that had been enriched 
for T  cells by PHA  stimulation.  Amplification of V01  to 
V05 gene segments from fetal liver cDNA resulted in bands 
for  V01  and  V02  reactions  on  ethidium  bromide-stained 
agarose gels that hybridized to an internal Co oligonucleo- 
tide probe. Among all three fetal liver samples as well as in 
a PBL sample from an adult volunteer, V~2 amplifications 
gave the strongest signal indicating that the majority of TCtL 
/~ chains in fetal liver and adult blood (10,  11, 22)  are rear- 
ranged to V~2. Trace amounts of V03, V04, and V05 were 
amplified from one fetal liver sample (FL 2/9)  (Fig.  1). 
To determine J0 gene usage of fetal liver TCR ~ chains, 
V0 gene segments were amplified from cDNA using V01 to 
V05 primers in combination with a Co primer followed by 
Southern blot hybridization with probes for Jal, J~2, and Js3 
gene segments. Hybridization of V02-C0 and V01-C0 reac- 
Figure 1.  Southern  blot anal- 
ysis  of  the TCR ~ chain  repertoire 
in human  fetal  liver.  TCR ~ chains 
were amplified from fetal liver 
cDNA using primers specific  for 
V/~I to V~5 gene segments in 
combination with a C~ primer. 
Southern  blots were  hybridized  to 
an internal 32p-labeled  C~ oligo- 
nucleotide  probe. (A) Fetal liver 
1/9; (B) fetal  liver 2/9; (C) fetal 
liver  2/27; (D) blood  cDNA  from 
an adult subject;  (E) negative  con- 
trol (no cDNA). 
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tions  to  a J~3  probe  gave  strong  signals  for all  fetal liver 
samples while weaker signals were detected using probes for 
Jbl  and J02  (Fig.  2).  In contrast, products from a V02-C0 
amplification using cDNA from adult blood T  cells gave a 
strong hybridization with a J01 probe; only trace amounts 
of V02-J03 rearrangements were detected in  adult  blood. 
This was expected as the majority of TCR/i chains in adult 
blood are rearranged to  the J01  gene segment (10).  These 
data indicate that V02-Js3 is the predominant TCR ~ chain 
rearrangement in human fetal liver and that V02 as well as 
V01  are preferentially rearranged to the J~3 gene segment. 
Sequence Analysis  of Vd  and  V~2 Rearrangements from 
Human Fetal  Liver Samples.  In both fetal livers (FL 2/27 and 
FL 2/9), the majority of V~2 gene segments were rearranged 
to J03  (22/24  sequences,  91.6%).  Also,  21  of 22  TCR/~ 
chains with a V~2-J~3 rearrangement carried the D~3 but not 
the D01 gene segment (Fig.  3). Only few, if any, N  region 
nudeotides were present at the VDJjunctions. An exception 
to this rule was sequence 9 (fetal liver 2/27), which contained 
an unusually long N region between Da3 and Jr3 consisting 
of a repeated TGAAACC(T)  sequence. All four V01  gene 
segments sequenced were also  rearranged to  D63  and J03 
(Fig.  3). V0-J0 rearrangements in fetal liver are therefore al- 
most  exclusively rearranged to  D03  and J03  with  limited 
junctional diversity. In contrast, TCR ~ chains from mature 
3'//~ T cells are most commonly rearranged to J01, use D01, 
D02, and D03 (frequently in tandem), and have extensive N 
region diversity (22-25). 
The predominant V02-J~3 gene rearrangement observed in 
these two fetal livers could result from a regulated rearrange- 
ment process or from positive selection of 3'//~ T cells bearing 
specific TCR chains. Since 7 of 22 V02-J03 sequences were 
in frame, the predominance of V02-D03-J03 rearrangements 
is most likely due to the presence of a regulated TCR ~ chain 
rearrangement process in human fetal fiver. The relative propor- 
tion of in-frame and out-of-frame rearrangements is consis- 
tent with the theoretical prediction that one-third of rear- 
rangements should lead to an in-frame sequence. 
Cloning of cr/fl and 7/8  T  Cells  from Human Fetal Liver. 
Since fetal liver 3'//~ T  cells with an unusual CD4+CD8 - 
phenotype have been described (13,  14),  it was of interest 
to determine TCR ~ chain rearrangements in fetal liver T 
cell clones with defined phenotypes. Fetal liver T cells were 
cloned by direct single cell cloning from fetal liver 5/27 (clones 
L3,  L6,  L7,  L25,  L38)  using  IL-2 as  well  as  irradiated 
mononuclear cells and an irradiated EBV-transformed B cell 
line (JY) as a feeder layer. T  cell clones were also generated 
from fetal liver 2/9 (clones L2G9, L4B2, L7F11, L4G1, L7F5) 
by magnetic bead selection of T  cells expressing the TCK 
c5 chain followed by in vitro expansion and single cell doning. 
Of the 10 clones generated (Fig.  4), six had surface expres- 
sion of the TCR ~ chain (mAb TCR-~I). Three of these 3,/~5 
T cell clones (L3, L7, and L2G9) had moderate levels of CD4 
expression,  while  clones  L4B2,  L25,  and  L7F11 were 
CD4- CDS-.  Some of the 3'h5 T  cell dones also had weak 
staining with the WT31 mAb; however, it is unlikely that 
these clones contained a second ot/fl T cell population since 
>99% of cells from each done were strongly stained by the Figure 2.  J~ gene usage  of TCR 
chains in human fetal  liver. Fetal 
liver cDNA was amplified using 
primers for Vel to V~5 in combi- 
nation with a C~ primer. Amplified 
products were  separated  on agarose 
gels and Southern  blots hybridized 
to J61, J62, and J~3 probes. Blood 
cDNA from  mature  T cells  was used 
as a positive  control, and negative 
controls included amplification  of 
V#I to V~5 with a Ce primer in the 
absence of cDNA. This analysis 
demonstrated  that in fetal  liver  both 
V#I  to  V~2  gene segments are 
predominantly rearranged to  the 
J~3 gene segment, while the ma- 
jority of V~I to V62 gene segments 
among mature blood T cells are 
rearranged to J~l. 
TCR-81 mAb. Four clones (L6, L38, L4G1, L7FS) expressed 
the TCR o~/3 as indicated by surface staining with the WT31 
mAb. Two of the oL/3 T  cell clones were CD4 + (L6, L38), 
while two other clones  were CD4+CD8 + (L4G1,  L7F5). 
Thus, two unusual phenotypes were observed  among these 
clones:  three of six clones that expressed  the TCR 8 chain 
had a  CD4+CD8 -  phenotype, while two  of four clones 
that expressed  the c~/3  TCR were CD4 § CD8 § . 
Three of the T  cell clones positive for the TCR-81 mAb 
were further characterized for surface  expression  of TCR 
V61-J~l gene segments (mAb 8TCS1),  the TCR Vs2 gene 
segment  (mAb  Ti3,A),  and  the TCR  V~2  gene  segment 
(mAb BB3). Three of four clones were found to express the 
TCR V62 gene segment, while only one clone was positive 
for expression of the V.~2 gene segment. These data confirm 
that  the TCR V#2  gene  segment is  the most  commonly 
used V~ gene segment by fetal liver 3'/8 T  cells. 
TCR 7  and r  Chain Rearrangements in Fetal Liver T  Cell 
Clones.  Sequence analysis of the TCR 8 chain from six fetal 
liver "y/8 T  cell clones demonstrated that all but one had a 
V~2-D~3-Je3 rearrangement with limited junctional diversity 
(Fig.  5).  The  V62-J~3 rearrangement of these  clones  was 
confirmed by genomic Southern blot analysis using probes 
for V~2 and J~3 (data not shown). Some clones showed strik- 
ingly similar protein sequences at the V~2-D~3-Je3 junction; 
clones L3 and L25 differed only by one residue at the V~2- 
D~3 junction, while clones L7 and L2G9 differed by two 
additional residues  present  at  the Ds-J~ junction of clone 
L2G9. These results indicate that the majority of fetal liver 
3~/8  T  cell  clones  with  CD4+CD8 -  and  CD4-CD8- 
phenotypes have V~2-De3-J~3 rearrangements with limited 
junctional diversity. 
To determine rearrangements of the TCR "y locus among 
these T  cell clones,  cDNA samples were amplified using a 
C-r oligonudeotide in combination with primers specific for 
Vs2-Vs4  gene segments and for the Vsl family, which has 
five functional members. Of the six clones studied, two had 
a single Vsl-Cs rearrangement (clones L4B2, L2G9) while 
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Figure  3.  Junctional diversity of 
TCR  6  chain.  Amplified TCR  t5 
chains  (V~I  and  V62)  from  two 
fetal livers were  cloned into  M13 
mp19 and sequenced by the dideoxy 
method.  (.4)  TCR.  ~5  chain  se- 
quences with a V62-J63 rearrange- 
ment; (B) TCR  t5 chain sequences 
with a V~2-J~2  rearrangement; (C) 
TCIL  6  chain  sequences  with  a 
V62-J~l rearrangement; (D) TCR t5 
chain  sequences  with  a  V~I-J~3 
rearrangement. The plus and minus 
signs  on  the far right  signify in- 
frame  or  out-of-frame  rearrange- 
ment,  respectively.  For  fetal liver 
2/9,  three M13 clones  were found 
to have the V61-J63 junctional se- 
quence of sample la. It is assumed 
that these sequences resulted from 
PCR  amplification  of  the  same 
cDNA  since  the stochastic  nature 
of  the  exonuclease  and  terminal 
transferase activities rarely gives rise 
to  TCR  /~  chains  with  identical 
junctional sequence. 
the  four  remaining  clones  had Vvl-C  v and Vv2-Cv  rear- 
rangements (clones L3, L7Fll) or Vv2-C-~ and V.~3-Cv rear- 
rangements (clones L7, L25) (Fig. 6 and Table 1). By sequence 
analysis of the Vv-Jv junction, all four V-r1 gene segments 
were found to be rearranged to J-r2.3; three members of the 
Vvl family (V~1.3,  Vvl.4,  Vvl.8) were represented among 
these four sequences (the V~1.8-Jv2.3 rearrangement was out 
of frame). In contrast, three of four V~2 gene segments were 
rearranged to J~1.2; both Vv3 segments were rearranged to 
Jr1.1. Thus,  there appears to be an ordered rearrangement 
process that results in preferential rearrangement of Vvl seg- 
ments to the Jr2 cluster (specifically Jr2.3)  and of Vv2 and 
Vv3  segments  to  the Jr1  cluster  (J-~1.2 and Jr1.1, respec- 
tively). While all clones had only one in-frame ~5 chain rear- 
rangement,  three of six clones were found to have two in- 
frame 3' chain rearrangements, in apparent violation of allelic 
exclusion.  However, other reports have indicated that two 
functional 6 or ct chain rearrangements can be found in some 
T cell clones and that allelic exclusion may not be complete 
(6, 26). 
The TCR 3, chain rearrangements observed among these 
fetal liver T cell clones are distinct from those that have been 
observed during thymic development. During early thymic 
development,  both  V-r1 and  V~2  were  found  to be rear- 
ranged to the Jr1 duster (Vvl.8-Jvl.1  and Vv2-Jyl.3, neither 
of which was present in the fetal liver T cell clones),  while 
3"/~ T cells that use Vv2-Jv2.3 rearrangements predominate 
in postnatal thymus  (6,  10). 
Discussion 
In mice, the fetal liver appears to be an extrathymic organ 
of 3'/~ T cell development  and maturation since intestinal 
intraepithelial 3'/t3 T cells can be reconstituted in lethally Jr- 
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Dyer #3 
Liver #7 
Liver 2G9 
Liver 4B2 
Liver #25 
Liver 7F11 
Liver #6 
Liver #38 
Liver 4G1 
L~ver 7F5 
CD3  CD4  CD8  WT31  TCR~51  ~STCS1  TrcA  BB3 
Figure  4.  FACS  ~ analysis of fetal 
liver T  cell clones. T  cell clones from 
fetal liver 5/27 (clones L3, L6, L7, 
L25, L38) and fetal liver 2/9 (clones 
L2G9, L4B2, L7F11, L4G1, L7F5) 
were  examined for  surface expres- 
sion of CD4 and CD8 antigens as 
well as crib and 3,//~ TCRs by in- 
direct immunofluorescence analysis. 
Antibodies used were: P3 (negative 
control),  T3b  (anti-CD3),  OKT4 
(anti-CD4),  Leu2A  (anti-CDS), 
WT31  (TCR ot//~ >> TCR 3,A5), 
TCP.-61 (anti-TCP. ~ chain), ~TCS1 
(anti-TCR  V~l-J~l),  Ti3,A  (anti- 
TCK  Vv9),  and  BB3  (anti-TCR 
Vs2). T  cell clones L3, L7, L2G9, 
L4B2,  L25,  and L7F11  were posi- 
tive for the TCR-~I mAb, while T 
cell clones I.,6, L38, L4G1, and L7F5 
were positive for the WT31 mAb. 
Three of the 3,/5 T  cell clones (L3, 
L7, L2G9) expressed moderate levels 
of CD4,  while  three  3'/5  T  cell 
clones  (clones L4B2,  L25,  L7F11) 
were CD4-CD8-.  Also, two ~x/3 
T  cell clones (L4G1,  L7F5)  had  a 
CD4 + CD8 §  phenotype. 
Nueleotide  seauenees 
Cloae  V~_2  N  Dx3  N 
zect  t,  umcaec 
Clone L3  geetgtgacae  ctggggga  g 
Clone L7  gcctgtgaca  t  aetgggggatae 
Clone L25  g~ctgtgaca  actggggga  g 
Clone L2G9  gectgtgaca  t  actgggggatacg  ca 
Clone L7FI 1  gcctgtgacacc  ggtgct  ctggg  tc 
Clone  V~_3  N  D,~3  N 
taett,  moe~  aet2n~atafg 
Clone LAB2  tactgtgcct  actggggga 
IJrotein  seouenees 
Clone L3  AlaCvsAso  Tla'Trp~ 
Clone L.25  hlaC'vsAso  AsnTr~dJ.  x 
eeoc [.7  /MaC'vsAso  lleLeu~LYAspThr 
Clone L2G9  Alg{2ggl~  lleLenGlvAsp Thr 
Clone LTFI 1  ,AlaCvsAsnThr  GlyAla  LeuGlv  Pro 
Clone L4B2  Ty~2/..iA  la  TyrTrp~J.xThr 
.l_x3  Rearrant~ment  In Frame 
ctcciffff 
ctcctgg  V~2-Dq$3-Jti3  + 
ctgg  V.$2-Dq53-J/i3  + 
ctcctgg  V62-D~-J63  + 
ctcctgg  V.52-D83-J63  § 
cctgg  V82-D63-J~3  + 
,1~2  Rearrangement  In Frame 
ctttgaca 
cmgaca  Vb3-D83-J~52  + 
SerSerTm 
SerSerTm 
Tm 
HlsSerTro 
Tro 
LeuThr 
Figure  5.  Sequence  analysis of the junctional  region 
of the TCR  ~ chain among fetal liver 3,/5 T  call clones. 
eDNA from fetal liver T  cell clones was amplified using 
primers for V~2 and C6. Amplified products were cloned 
into M13 mpl9 and sequenced by the dideoxy method. 
Five of six clones were found to have a V,2-D63-JD  rear- 
rangement with little N  region diversity,  one clone had 
a  V~3-D~3-J,2  rearrangement. 
Nucleotide  seouences 
Clone  Vx 
Clone L3  tactgtgccacctg 
Clone L2G9  tactgtgccacctggga 
Clone LAB2  tactgtgccacctgggacaggc 
Clone L7FI 1  tactgtgccacctgggatgggc 
Clone L3  tactg~gccttgtgggaggtg 
Clone L7  tactgtgccttgtgggaggtg 
Clone L25  tactgtgccttgtgggag 
Clone L7FI 1  tactgtgccttgtgggaggtg 
Clone L7  tactgtgctgcgtgg 
Clone L25  tactgtgctgcgtgg 
Protein  seouences 
Clone L2G9  TyrCysAlaThrTrpAsp 
Clone LAB2  TyrCysAlaThrTrpAspArg 
Clone L7FI 1  TyrCysAiaTlarTrpAspGly 
Clone L3  TyrCysAlaLe  uTrpOluVal 
Clone L7  TyrCysAlaLe  uTrpGlu  Val 
Clone L25  TyrCysAlaLeuTrpGlu 
Clone L7F11  TyrCy  sAlaLe  uTrpGlu  V',d 
Clone L7  TyrCysAlaAlaTrp 
Clone L25  TyrCysAlaAlaTrp 
N  |e  Rearrangement  In Fr~lmf 
ag  attataagaaactcttt  V~,I 8 - J~,2 3 
ttattataagaaactcttt  V-tl.4 - Jy2 3  + 
c  ttataagaaactcrrt  VyI.3 - J,t  2 3  + 
cc  aagazactcttt  V~,I.4 - Jy2 3  + 
caagagltgggt,  daa  V~,2  J-el 2  + 
c  agttgggcaaa  V.r  - Jyl  2  + 
eaagagttgggcaaa  Vy2 - J,/l 2  + 
cgag  aactctttggcagtgg  V/2 - Jy2 3  + 
gatt  ccactggttggtt  Vy3 - JyI  I  + 
gatt  ataccactggttggtt  Vy3 - Jyl  1  + 
TyrTyrLysLysLeuPheGlySerGly 
Pro  TyrLysLysLeuPheGlySerGly 
Pro  LysLysLeuPheGlySerGly 
GInGluLeuGlyLysLyslleLysValPheGlyProGly 
Gin  LeuGlyLysLy  slleLysValPheGlyProGly 
GlnGluLeuGlyLysLyslleLysValPheGlyProGly 
ArgGlu  LeuPheGlySerGly 
AspSer  ThrGlyTrpPheLysllePheAlaGluGly 
AspTyrThr  ThrGlyTrpPheLyslle  PheAlaGluGly 
Figure  6.  Sequence analysis of the junctional region of the 
TCR  3" chain among fetal liver 3,/5 T  cell clones.  Vv gene 
usage was determined by amplification of cDNAs with primers 
for  Vyl-Vv4  in combination  with  a  C~  primer.  Amplified 
products  were cloned into  pCKII  (TA cloning system) and 
double-stranded plasmid DNA was sequenced by the dideoxy 
method. Note that clone LTF11 was found to have an in-flame 
Vv2-Jv2.3  sequence (in addition  to an in-flame Vv1.4-J~2.3 
rearrangement) even though the T  cell clone was not recog- 
nized by the  mAb  Ti3,A.  It  is  therefore  assumed that  the 
vv2-J~2.3  sequence originated from a second T  cell popula- 
tion  present  in the original  clone. 
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Ti3,A/BB3 
Clone  Phenotype  staining  V~-J~  In frame  V~-D~-J~  In frame 
ND  + 
ND  + 
L3  CD4 §  CD8- 
L7  CD4 +  CD8- 
L2G9  CD4 +  CD8- 
L25  CD4- CD8- 
L7F11  CD4-CD8- 
L4B2  CD4-CDS- 
--  + 
+  + 
--  + 
vv2-Jvl.2 
Vvl.8-Jv2.3 
vv2-J~l.2 
vv3-J~l. 1 
Vvl.4-Jv2.3 
vv2-Jvl.2 
v~3-Jvl. 1 
vv1.4-J~2.3 
vv2-J~2.3 
Vvl.3-Jv2.3 
+  V~2-D63-Jb3 
+  V~2-D63-J~3 
-6 
+  V~2-D~3-J~3 
+  V~2-D63-J63 
-6 
+  V62-D63-J63 
-6 
+  V~3-Db3-J~2 
+ 
+ 
+ 
+ 
radiated mice after injection of fetal liver precursors, even in 
the absence of a thymus. Also, nude mice were found to have 
substantial numbers of intestinal intraepithelial 3'/6 T  cells 
despite the almost complete absence of c~/3 T  cells.  This 
demonstrates that at least a subset of 3"/6 T cells is thymus 
independent and that the fetal liver is at least one likely site 
of extrathymic maturation (12).  These results also suggest 
that the initial repertoire selection may take place in the fetal 
liver.  Previous studies have demonstrated that thymic 3'/6 
T  cells  can  undergo both  positive and  negative selection 
(27-29), and this selection may also take place in the fetal liver. 
During 3'/6 T cell development in mice, a sequential matu- 
ration of 3'/6 T cells with defined TCR 3' and ~ chain rear- 
rangements can be observed (4, 30). 3"//~ T cells with invar- 
iant receptors mature early and migrate to specific epithelial 
organs, while 3'/6 T cells with greater receptor diversity ma- 
ture later and localize to the spleen (3-5). Even though the 
maturation process of human 3"/6 T cells is not as well un- 
derstood, there is evidence for a sequential appearance of 3'//~ 
T cells bearing specific receptors during thymic development. 
Vv1.8-Jvl.1/V~2-J~3 rearrangements are present in early fetal 
thymus, while Vs2-Jv2.3/V61-J61  represent the most com- 
mon 3" and ~ chain rearrangements in postnatal thymus (6, 
10). Presumably due to extrathymic events, 3"/6 T cells with 
Vv2-Jsl.2/V~2-Jel rearrangements become the major 3//6 T 
cell population in blood during childhood (10,  11,  25). 
A comparison of TCR 6 chain sequences in human fetal 
thymus to the present results in human fetal liver demon- 
strates that similar TCR 6 chain rearrangements are found 
at both sites  of T  cell maturation.  In both fetal liver and 
thymus,  a  predominant  V~2-D~3-Je3 rearrangement with 
little N  region diversity is seen (6,  7).  In contrast, 3' chain 
rearrangements of3"/6 T cells from fetal thymus (6) and fetal 
liver are different. During early thymic development, both 
Vsl and Vv2 are rearranged to the Jsl cluster (Vvl.8-Jsl.1 
and Vs2-Jvl.3),  while Vv2-Js2.3  rearrangements predomi- 
nate during late stages of thymic development (6, 10). In fetal 
liver, however, an ordered rearrangement process results in 
preferential  rearrangement  of  Vsl  segments  to  the Js2 
cluster (specifically J-r2.3) and of V~2 and V~3 segments to 
the Jr1 cluster (J~1.2 and J~1.1, respectively). Fetal liver 3'/6 
T cells may therefore have specificities different from 3'/6 T 
cells that mature in the thymus. 
A subset of human fetal liver 3'/6 T cells ('~20%) has an 
unusual CD4 phenotype (13, 14). Among the six fetal liver 
3'//~ T cell clones established in this study, three were found 
to express moderate levels of CD4 and to use TCR 6 chains 
with a V~2-D~3-J~3 rearrangement. Such fetal liver 3'//~ T 
cells  may have  a  specialized  immune  function  as  CD4 + 
CDS-  3'/6 T  cells from fetal liver do not possess  an NK- 
like cytotoxic activity  observed among  CD4-CD8 +  and 
CD4-CD8-  3'//} T  cells  (13).  CD4+CD8 -  3"/6 T  cells 
from adult blood, which constitute a minor subpopulation 
of mature 3"/6 T  ceils, were also found to be functionally 
different from CD4-CD8-  and CD4-CD8 + 3'/6 T cells as 
they provide help for B cells but lack cytotoxic activity (15). 
Thus, fetal liver 3'/6 T ceils, in particular the CD4 +  CD8- 
subset, may have specific functions in the fetal immune system. 
The identification of ligands for fetal liver 3'/6 T ceUs would 
further our understanding of 3'/c3 T  cells and their role in 
immune recognition during development. 
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431  Wucherpfennig  et al. Note added in Froofi T cell receptor 3` and c$ chain rearrangements similar to those found in fetal liver T 
cell clone L4B2 have been described  for autoaggressive  3`/~ T  cells from a case of polymyositis.  These 
muscle-infiltrating T  cells use a V~2-D#3-J63/V3`1.3-J3`1.3  03"1.3 is identical to J3'2.3 at the protein 
level) but have longer N  regions than the fetal liver T  cell clone (31). 
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